Mode
Text Size
Log in / Sign up

Resveratrol supplementation significantly reduces LDL-C but lacks consistent impact on glycemic indices in type 2 diabetesResveratrol fails to improve blood sugar in type 2 diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that resveratrol shows significant LDL-C reduction but lacks consistent efficacy for glycemic control in type 2 diabetes.

This umbrella review and meta-analysis synthesized data from 10 meta-analyses to evaluate the impact of resveratrol supplementation on glycemic indices and lipid profiles in patients with type 2 diabetes. The analysis focused on primary outcomes including fasting blood sugar, HbA1c, insulin, and HOMA-IR, alongside secondary lipid markers such as LDL-C, HDL-C, triglycerides, and total cholesterol.

The authors found no significant effects for the majority of glycemic indicators, including fasting blood sugar, HbA1c, insulin, HOMA-IR, HDL-C, triglycerides, and total cholesterol. However, a significant reduction in LDL-C was reported. Additionally, a significant decline in serum insulin levels was observed specifically when the sample size was greater than or equal to 500 and the study number was greater than or equal to 10.

The authors noted high heterogeneity among the included studies as a primary limitation. Due to these limitations and the underlying quality of the meta-analyses, resveratrol is not currently considered a beneficial agent for improving glycemic indices or lipid profiles in patients with type 2 diabetes.

How this fits prior evidence

This umbrella review addresses a gap regarding the efficacy of nutraceutical interventions like resveratrol in managing type 2 diabetes. While this study found no significant effects on glycemic markers, it contrasts with other management strategies such as SGLT2 inhibitors which are associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes, and semaglutide which reduces risk of kidney decline or death in patients with type 2 diabetes.

A large analysis of multiple studies found that resveratrol supplements do not help control blood sugar or improve most cholesterol levels in people with type 2 diabetes. The review combined results from 10 meta-analyses, which themselves pooled data from many smaller studies. Researchers looked at effects on fasting blood sugar, HbA1c, insulin, insulin resistance, HDL cholesterol, triglycerides, and total cholesterol. For all of these, resveratrol showed no significant benefit.

There was one exception: LDL cholesterol (the "bad" cholesterol) did decrease significantly. Also, in larger studies with at least 500 participants, serum insulin levels dropped. However, the overall evidence was weak because the studies varied widely in design and quality. The review did not report any safety issues, but that does not mean resveratrol is risk-free.

Because the results are mixed and the underlying studies are inconsistent, experts say resveratrol is not a helpful treatment for managing blood sugar or cholesterol in type 2 diabetes. People with diabetes should focus on proven treatments and lifestyle changes, and talk to their doctor before trying any supplement.

What this means for you:
Resveratrol supplements do not meaningfully improve blood sugar or cholesterol in type 2 diabetes.

Common questions

Does resveratrol help lower blood sugar in type 2 diabetes?

No, this review found that resveratrol did not significantly lower fasting blood sugar, HbA1c, or insulin levels in people with type 2 diabetes. Only in very large studies was a small drop in insulin seen, but overall the evidence does not support using resveratrol for blood sugar control.

Does resveratrol improve cholesterol levels?

Resveratrol did not improve HDL cholesterol, triglycerides, or total cholesterol. It did lower LDL cholesterol (the bad kind) significantly, but the overall effect on lipid profile was not considered beneficial enough to recommend resveratrol for cholesterol management in type 2 diabetes.

Is resveratrol safe for people with type 2 diabetes?

The review did not report any safety issues, but that does not mean resveratrol is completely safe. Because the studies varied widely and no adverse events were mentioned, it is best to talk to your doctor before taking resveratrol, especially if you are on other medications.

Should I take resveratrol for my type 2 diabetes?

Based on this review, resveratrol is not recommended for managing blood sugar or cholesterol in type 2 diabetes. The evidence shows no significant benefits for most outcomes. Always consult your doctor before starting any supplement, as it may interact with your current treatment.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Growing evidence supports the therapeutic role of nutraceuticals as complementary and alternative therapies in patients with type 2 diabetes mellitus (T2DM). Resveratrol, a natural polyphenol compound has been shown to modulate metabolically disturbances include insulin resistance and lipid profile disturbances. OBJECTIVES: This umbrella review and meta-analysis study conducted to assess the effect of resveratrol on glycemic indices and lipid profile in T2DM. METHODS: The study was performed by using the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines (PRISMA) checklist. The PubMed, Web of Sciences, and Google Scholar databases were used to search the published papers up to 2025. The AMSTAR questionnaire was used for assessing the quality of eligible studies. Additionally, The Cochran Q test and I statistics were used for examining heterogeneity. RESULTS: Of 10 meta-analyses evaluating the resveratrol effects on glycemic indices and lipid profile showed no significant effects on fasting blood sugar, glycosylated hemoglobin A1c (HbA1c), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), triglyceride (TG), total cholesterol (TC), despite significant heterogeneity. Nevertheless, based on SMD analyses, resveratrol supplementation showed only significant effects on LDL-C reduction. Also, significant decline in serum insulin level was observed for sample size ≥ 500 and study number ≥ 10. CONCLUSION: Given the high heterogeneity and limitations attributed to the study, resveratrol supplementation was not considered as a beneficial agent in declining glycemic indices and lipid profile in patients with T2DM.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.